Clinical Trials Results - National Cancer Institute

	Quick Links


	Director's Corner Dictionary of Cancer Terms NCI Drug Dictionary Funding Opportunities NCI Publications Advisory Boards and Groups Science Serving People Español

Questions about cancer?

	NCI Highlights


	High Dose Chemotherapy Prolongs Survival for Leukemia Prostate Cancer Study Shows No Benefit for Selenium, Vitamin E Past Highlights



Results: 1 -4 of 4 Show results per page	View Search Criteria \| Help With Results

Last Modified: 10/10/2008 First Published: 7/23/2004


1.		Phase I Study of 17-Dimethylaminoethylamino-17-demethoxygeldanamycin (17-DMAG) in Patients With an Advanced Solid Tumor or Lymphoma

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase I				Treatment				Closed				18 and over				NCI				NCI-04-C-0218 04-C-0218, 6544, NCI-6544, NCT00088868

Last Modified: 11/2/2007 First Published: 7/23/2004


2.		Phase I Study of 17-Dimethylaminoethylamino-17-Demethoxygeldanamycin (17-DMAG) in Patients With Metastatic or Unresectable Solid Tumors or Lymphomas

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase I				Treatment				Closed				18 and over				NCI				PCI-03-153 6548, NCI-6548, PCI-IRB-0404083, NCT00089271

Last Modified: 1/28/2008 First Published: 7/23/2004


3.		Phase I Study of 17-Dimethylaminoethylamino-17-Demethoxygeldanamycin (17-DMAG) in Patients With Metastatic or Unresectable Solid Tumors

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase I				Treatment				Closed				18 and over				NCI				MSKCC-04053 6542, NCI-6542, NCT00089362

Last Modified: 7/21/2008 First Published: 9/16/2005


4.		Phase I Study of 17-Dimethylaminoethylamino-17-Demethoxygeldanamycin (17-DMAG) in Patients With Unresectable or Metastatic Solid Tumors

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase I				Treatment				Closed				18 and over				NCI				ICR-PH1/102 NCI-6547, 6547, NCT00248521

Select All on One Page